Smoking cessation: an economic analysis and review of varenicline.

Clinicoecon Outcomes Res · 2009 · PMC3169991 · PMID 21935304

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

did not reach statistical significanceP = 0.056so close (0.05 < p ≤ 0.1)

The CQR at week 52 did not reach statistical significance, but still favored varenicline (26.1% vs 20.3% vs nicotine, P = 0.056).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.